FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983280179> ?p ?o ?g. }

• W1983280179 endingPage "388" @default.
• W1983280179 startingPage "380" @default.
• W1983280179 abstract "Malignant mesothelioma (MM) is a very aggressive asbestos-related neoplasm of the serous membranes, whose incidence is increasing worldwide. Although the introduction of new drug combinations, such as cisplatin plus pemetrexed/gemcitabine, has determined an improvement in the patient quality of life, MM remains a universally fatal disease. The observation that key G 1/S checkpoint regulators are often functionally inactivated in MM prompted us to test whether the use of G 2/M checkpoint inhibitors, able to sensitize G 1/S checkpoint-defective cancer cells to DNA-damaging agents, could be successful in MM. We treated six MM cell lines, representative of different histotypes (epithelioid, biphasic, and sarcomatoid), with cisplatin in combination with MK-1775, an inhibitor of the G 2/M checkpoint kinase WEE1. We observed that MK-1775 enhanced the cisplatin cytotoxic effect in all MM cell lines, except the sarcomatoid cell line, which is representative of the most aggressive histotype. As expected, the enhancement in cisplatin toxicity was accompanied by a decrease in the inactive phosphorylated form of cyclin-dependent kinase 1 (CDK1), a key substrate of WEE1, which is indicative of G 2/M checkpoint inactivation. Consistently, we also observed a decrease in G 2/M accumulation and an increase in mitotic entry of DNA-damaged cells and apoptosis, probably due to the loss of the cell ability to arrest cell cycle in response to DNA damage, irrespectively of p53 mutational status. Notably, this treatment did not increase cisplatin cytotoxicity on normal cells, thus suggesting a possible use of MK-1775 in combination with cisplatin for a safe and efficient treatment of epithelioid and biphasic MM." @default.
• W1983280179 created "2016-06-24" @default.
• W1983280179 creator A5001461937 @default.
• W1983280179 creator A5020300685 @default.
• W1983280179 creator A5024798356 @default.
• W1983280179 creator A5040020004 @default.
• W1983280179 creator A5045657404 @default.
• W1983280179 creator A5050629113 @default.
• W1983280179 creator A5054345541 @default.
• W1983280179 creator A5071034120 @default.
• W1983280179 creator A5074082081 @default.
• W1983280179 date "2014-01-14" @default.
• W1983280179 modified "2023-09-26" @default.
• W1983280179 title "Abrogating G₂/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma" @default.
• W1983280179 cites W1510669790 @default.
• W1983280179 cites W1592064949 @default.
• W1983280179 cites W1840165714 @default.
• W1983280179 cites W1982084759 @default.
• W1983280179 cites W1989106838 @default.
• W1983280179 cites W1991403537 @default.
• W1983280179 cites W1991595805 @default.
• W1983280179 cites W1998588464 @default.
• W1983280179 cites W2021872745 @default.
• W1983280179 cites W2028495676 @default.
• W1983280179 cites W2035263093 @default.
• W1983280179 cites W2039280709 @default.
• W1983280179 cites W2039442869 @default.
• W1983280179 cites W2042740031 @default.
• W1983280179 cites W2045000084 @default.
• W1983280179 cites W2055128522 @default.
• W1983280179 cites W2063389371 @default.
• W1983280179 cites W2068643937 @default.
• W1983280179 cites W2073606614 @default.
• W1983280179 cites W2074545297 @default.
• W1983280179 cites W2077945404 @default.
• W1983280179 cites W2092236963 @default.
• W1983280179 cites W2093442957 @default.
• W1983280179 cites W2095824051 @default.
• W1983280179 cites W2096293110 @default.
• W1983280179 cites W2097803438 @default.
• W1983280179 cites W2103342448 @default.
• W1983280179 cites W2109199074 @default.
• W1983280179 cites W2113684644 @default.
• W1983280179 cites W2133966895 @default.
• W1983280179 cites W2134123784 @default.
• W1983280179 cites W2142325694 @default.
• W1983280179 cites W2148636166 @default.
• W1983280179 cites W2150014472 @default.
• W1983280179 cites W2163208652 @default.
• W1983280179 cites W2164394541 @default.
• W1983280179 cites W2324734776 @default.
• W1983280179 cites W4211134618 @default.
• W1983280179 doi "https://doi.org/10.4161/cbt.27623" @default.
• W1983280179 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3979815" @default.
• W1983280179 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24365782" @default.
• W1983280179 hasPublicationYear "2014" @default.
• W1983280179 type Work @default.
• W1983280179 sameAs 1983280179 @default.
• W1983280179 citedByCount "24" @default.
• W1983280179 countsByYear W19832801792014 @default.
• W1983280179 countsByYear W19832801792015 @default.
• W1983280179 countsByYear W19832801792017 @default.
• W1983280179 countsByYear W19832801792018 @default.
• W1983280179 countsByYear W19832801792020 @default.
• W1983280179 countsByYear W19832801792021 @default.
• W1983280179 countsByYear W19832801792022 @default.
• W1983280179 crossrefType "journal-article" @default.
• W1983280179 hasAuthorship W1983280179A5001461937 @default.
• W1983280179 hasAuthorship W1983280179A5020300685 @default.
• W1983280179 hasAuthorship W1983280179A5024798356 @default.
• W1983280179 hasAuthorship W1983280179A5040020004 @default.
• W1983280179 hasAuthorship W1983280179A5045657404 @default.
• W1983280179 hasAuthorship W1983280179A5050629113 @default.
• W1983280179 hasAuthorship W1983280179A5054345541 @default.
• W1983280179 hasAuthorship W1983280179A5071034120 @default.
• W1983280179 hasAuthorship W1983280179A5074082081 @default.
• W1983280179 hasBestOaLocation W19832801791 @default.
• W1983280179 hasConcept C105696609 @default.
• W1983280179 hasConcept C120504264 @default.
• W1983280179 hasConcept C121608353 @default.
• W1983280179 hasConcept C126322002 @default.
• W1983280179 hasConcept C142724271 @default.
• W1983280179 hasConcept C143425029 @default.
• W1983280179 hasConcept C184235292 @default.
• W1983280179 hasConcept C186000732 @default.
• W1983280179 hasConcept C190283241 @default.
• W1983280179 hasConcept C2776694085 @default.
• W1983280179 hasConcept C2777240266 @default.
• W1983280179 hasConcept C2777407522 @default.
• W1983280179 hasConcept C2778239845 @default.
• W1983280179 hasConcept C2780258809 @default.
• W1983280179 hasConcept C2781252693 @default.
• W1983280179 hasConcept C29537977 @default.
• W1983280179 hasConcept C50001416 @default.
• W1983280179 hasConcept C502942594 @default.
• W1983280179 hasConcept C54086632 @default.
• W1983280179 hasConcept C54174078 @default.
• W1983280179 hasConcept C552990157 @default.

• next